Global office locator

Biopsies remain the gold standard in MASH clinical trials, but they are far less common in everyday clinical practice. As more patients are diagnosed and managed using non-invasive tests, the gap between routine care a...

Connect with ICON’s hepatology experts at AASLD, booth \#1861, to explore how we can support your liver disease trials, from smarter site selection powered by AI and expert insight to imaging, biomarkers and endpoint str...

Rare disease studies demand flexibility. Digital solutions and decentralised models can help reduce patient burden, improve access and support participation. Meet the ICON team at #WorldOrphanEU, booth \#313, to discuss ...

Drop by booth \#69 at #OCTNewEngland2026, 27– 28 October. Meet the ICON team to explore new solutions to common issues within clinical trials. Learn how we can simplify processes to help you meet critical milestones, on ...

Approval is not access. EMA marketing authorisation does not guarantee a positive reimbursement outcome. Under JCA, sponsors must show relative clinical effectiveness and safety through evidence that reflects European p...

As we recognise #NationalLiverAwarenessMonth, we're highlighting the importance of advancing research in liver disease. In the past 5 years, ICON has participated in 98 hepatology studies across a range of indications in...

Our colleagues in Peru came together to recognise Breast Cancer Awareness Month and help raise awareness of the importance of prevention and early detection. Wearing pink and the pink ribbon, the team took part in a wel...

It was a fantastic few days in Orlando, connecting with colleagues from across the clinical research community, exchanging ideas and hearing perspectives from both sites and sponsors on how we can work together to improv...

ICON are proud to be the platinum sponsor of this year's TOPRA Symposium, which brings together regulatory professionals from across industry, regulatory bodies and academia to exchange perspectives on the future of heal...

Heading to #OCTDACH? Visit ICON at booth \#6. Our team will be on-site to discuss the trends, challenges, and opportunities shaping the future of clinical research and digital health. Whether you're looking to optimise t...

Q: When should key COA decisions be made? A: Before the endpoint is locked. Join our upcoming webinar to learn how early decisions around COA selection and development can: - Strengthen evidence generation - Reduce...

How hard do you work to choose the right research publishing platform? Probably too hard. We can make it easier for you. PubsHub Journals and Congresses has information on over 10,000 entries with over 50 fields of data ...